Case Report: Toripalimab plus Anlotinib in Postoperative Recurrent Renal Pelvic Sarcomatoid Urothelial Carcinoma

Overview of attention for article published in Frontiers in oncology, September 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter: 1 X user

So far, Altmetric has seen 1 X post from an account with 28 followers.

$CHRS https://t.co/MBYTRmn4kR

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.